EQTY
Kovitz Core Equity ETF
Set alert
29.57 USD -0.34 -1.15%
29.47 Day range 29.85
24.80 52-week range 30.01
- YTD
- +9.58%
- 1 year
- +14.54%
- Open
- 29.85
- Prev close
- 29.92
- Mkt cap
- 1.41B
- Vol
- 12.04K
- Avg vol
- 46.40K
- EPS
- 1.12
- P/E
- 26.43
- Div yield
- 0.00%
More statistics
- Low
- 29.47
- High
- 29.85
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 29.40
- 200-d avg
- 28.03
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 26.37
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 29.40
- 200-day average
- 28.03
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Kovitz Core Equity ETF
The fund invests primarily in equity securities of U.S. and foreign companies. Equity securities in which the fund may invest include common stocks and common stock equivalents (such as rights or warrants, which give the fund the ability to purchase the common stock, and convertible securities, which are securities that are convertible into the common stock). The fund may invest in companies of any market capitalization, including small- and mid-capitalization companies.
News
- Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year
- Danaher Brings NVIDIA AI Into Scientific Instruments in Push for Faster Discoveries
- EXCLUSIVE: IRS Targets Section 351 ETF Tax Strategy: What Investors Need To Know
- Analog Devices to Buy Alif Semiconductor for $1.35 Billion
- Aon Bets $17B On USI To Strengthen US Middle-Market Business
- Motorola Solutions Buys D-Fend For $1.5 Billion Deal
- Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026
- Earnings Just Put Dan Loeb's Bets To The Test — Here's What Held Up
- CarMax Accelerates Used Car Sales Growth, Despite Earnings Miss
Your note
Sign in to keep a note on EQTY — it syncs with the Stock Master app.